Royal Bank of Canada’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22K | Sell |
5,783
-160,680
| -97% | -$611K | ﹤0.01% | 5847 |
|
|
2025
Q1 | $754K | Sell |
166,463
-5,435
| -3% | -$24.6K | ﹤0.01% | 3368 |
|
|
2024
Q4 | $1.22M | Buy |
171,898
+4,810
| +3% | +$34K | ﹤0.01% | 2981 |
|
|
2024
Q3 | $1.36M | Sell |
167,088
-49,518
| -23% | -$403K | ﹤0.01% | 2923 |
|
|
2024
Q2 | $1.38M | Buy |
216,606
+2,802
| +1% | +$17.9K | ﹤0.01% | 2882 |
|
|
2024
Q1 | $1.61M | Sell |
213,804
-15,389
| -7% | -$116K | ﹤0.01% | 2748 |
|
|
2023
Q4 | $2.12M | Sell |
229,193
-69,952
| -23% | -$648K | ﹤0.01% | 2599 |
|
|
2023
Q3 | $3.03M | Sell |
299,145
-16,155
| -5% | -$163K | ﹤0.01% | 2160 |
|
|
2023
Q2 | $3.94M | Buy |
315,300
+1,564
| +0.5% | +$19.5K | ﹤0.01% | 1995 |
|
|
2023
Q1 | $3.66M | Buy |
313,736
+26,127
| +9% | +$305K | ﹤0.01% | 2063 |
|
|
2022
Q4 | $3.06M | Sell |
287,609
-44,495
| -13% | -$473K | ﹤0.01% | 2208 |
|
|
2022
Q3 | $3.22M | Buy |
332,104
+3,093
| +0.9% | +$30K | ﹤0.01% | 2120 |
|
|
2022
Q2 | $4.77M | Sell |
329,011
-122,508
| -27% | -$1.78M | ﹤0.01% | 1862 |
|
|
2022
Q1 | $11.8M | Buy |
451,519
+34,091
| +8% | +$891K | ﹤0.01% | 1405 |
|
|
2021
Q4 | $16.5M | Buy |
417,428
+140,387
| +51% | +$5.56M | ﹤0.01% | 1310 |
|
|
2021
Q3 | $13.9M | Buy |
277,041
+16,534
| +6% | +$827K | ﹤0.01% | 1408 |
|
|
2021
Q2 | $14.5M | Buy |
260,507
+2,735
| +1% | +$152K | ﹤0.01% | 1408 |
|
|
2021
Q1 | $12.1M | Buy |
257,772
+11,106
| +5% | +$519K | ﹤0.01% | 1444 |
|
|
2020
Q4 | $10.7M | Sell |
246,666
-43,109
| -15% | -$1.88M | ﹤0.01% | 1447 |
|
|
2020
Q3 | $10.6M | Sell |
289,775
-4,786
| -2% | -$175K | ﹤0.01% | 1313 |
|
|
2020
Q2 | $8.59M | Buy |
294,561
+294,471
| +327,190% | +$8.59M | ﹤0.01% | 1406 |
|
|
2020
Q1 | $2K | Sell |
90
-16,063
| -99% | -$357K | ﹤0.01% | 5788 |
|
|
2019
Q4 | $561K | Buy |
16,153
+230
| +1% | +$7.99K | ﹤0.01% | 3355 |
|
|
2019
Q3 | $503K | Buy |
+15,923
| New | +$503K | ﹤0.01% | 3311 |
|